Knowing Yoga with Dinesh Kashikar

Dinesh Kashikar addressing a yoga press conference in Russia. (Continued from Part-1 – Dinesh Kashikar: Journeying with The Yogi) In the first part to Dinesh Kashikar’s interview, we explored his yoga journey through the years, how it all began, how he started teaching Art of Living Yoga, and his interests in life. In the second […]

Read More →
Ignorance is the root cause of Suffering

Change is the only permanent phenomenon. Patanjali Yoga Sutra Knowledge Sheet 55 Contd. from knowledge sheet 54 Ignorance is the root cause of Suffering “Tapaha-swadhya-ayaeshwara-pranidhana-kriya-yogaha”. (II Sūtra 1) This is the kriya yoga or yoga of action. Even while doing an activity, see that you are not doing it. Be a silent witness. There is […]

Read More →
Your Five Sources of Misery

This craving makes you miserable. Patanjali says that there are only five sources of misery. There is no sixth source of misery. Ignorance, or thinking that which is changing as non-changing. We try to control others mind saying that they should be this way, that way. How is it possible? Someone may have had love […]

Read More →
A journey within with YOGA NIDRA

Relax better with Yog Nidra. Yoga Nidra or “yogic sleep” is an ancient practice which is little known to common people, but is getting a lot of attention due to its therapeutic effects on mind and body. It was spring of 2008 and I was looking for some refreshing yoga classes, because I wanted to […]

Read More →
Preventing motion sickness through yoga

Overcome motion sickness through yoga. ••• My family loves to travel, especially by road and loves to cruise! As for me, until a year ago, it was a dreaded time! Motion sickness and I were best buddies when it came to car rides…at least when I’d be in the back seat…and  cruises were the closest […]

Read More →
Aurobindo Pharma gets final USFDA nod for gastro reflux drug

Drug firm Aurobindo Pharma has received final approval from the USFDA to manufacture and market pantoprazole sodium for injections, used for the treatment of gastroesophageal reflux disease, in the American market. “The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market pantoprazole sodium for injections, 40 mg/vial,” […]

Read More →
Lupin gains on launch of first product from GAVIS pipeline in the US

Lupin LUPIN LTD LIVE STOCK PRICE – CLICK HERE FOR MORE BSE 1,540.7534.20 (2.27%) NSE 1,540.1030.35 (2.01%) BSE NSE 12:0015:001,5001,5101,5201,5301,5401,5501,560 12:00 2Y1Y6M1M5D1D ALSO READ Rebound in US sales a big positive for LupinPharma major Lupin targets $1 bn revenue from inorganic growth by FY18Lupin’s US growth falters againUS business on road to recovery: Vinita GuptaLupin […]

Read More →
The Global Fund stops sourcing anti-malaria drugs from Ipca

The Global Fund, a Geneva-based public partnership organisation, has discontinued sourcing of anti-malaria drugs (Artemisinin based Combination Therapy, or ACTs) from Ipca Laboratories in the light of the US Food and Drug Administration (FDA)’s warning letter to the drug maker’s three plants. The move is a setback to Ipca Laboratories, a domestic market leader in […]

Read More →
‘Wait till tomorrow to fall ill’: On #WorldHealthDay, Twitter dispenses strange (and sage) advice

The #WorldHealthDay started on Thursday on an uneasy note. The World Health Organisation, celebrating its birthday, released its first ever global report on diabetes to spread awareness about the disease. And the findings were disconcerting. Diabetes will be the seventh leading cause of death in 2030, WHOpredicted. The number of adults living with the disease […]

Read More →
Glenmark gets two ANDA approvals from USFDA

Image via Shutterstock Glenmark gets FDA nod for generic fungal skin infections creamGlenmark gets tentative nod from USFDA for azelaic acid gelGlenmark Pharma gets USFDA nod for two generic drugsGlenmark gets tentative nod from USFDA for epilepsy drugGlenmark Pharma surges on receiving tentative approval from USFDA Glenmark Pharmaceuticals has received final approval from the US […]

Read More →